BIOCON BIOLOGICS UK LIMITED

Company number 10038295

Date	Type	Description	View / Download
15 Apr 2021	SH01	Statement of capital following an allotment of shares on 10 April 2021 GBP 116,771,297 USD 100,000,000	(3 pages)
14 Apr 2021	CH01	Director's details changed for Paul Fredrick Blackburn on 1 April 2021	(2 pages)
09 Apr 2021	CS01	Confirmation statement made on 2 March 2021 with updates	(5 pages)
06 Apr 2021	SH01	Statement of capital following an allotment of shares on 17 March 2021 GBP 116,771,297 USD 50,000,000	(3 pages)
22 Mar 2021	MA	Memorandum and Articles of Association	(38 pages)
22 Mar 2021	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES01 ‐ Resolution of adoption of Articles of Association	(1 page)
09 Feb 2021	AP01	Appointment of Paul Fredrick Blackburn as a director on 19 January 2021	(2 pages)
05 Feb 2021	AP01	Appointment of Ravi Rasendra Mazumdar as a director on 19 January 2021	(2 pages)
30 Nov 2020	AA	Full accounts made up to 31 March 2020	(33 pages)
19 Oct 2020	CERTNM	Company name changed biocon biologics LIMITED\certificate issued on 19/10/20 NM04 ‐ Change of name by provision in articles	(2 pages)
16 Mar 2020	CS01	Confirmation statement made on 2 March 2020 with updates	(4 pages)
05 Mar 2020	CH01	Director's details changed for Mr John Russell Fotheringham Walls on 21 February 2020	(2 pages)
23 Sep 2019	AA	Full accounts made up to 31 March 2019	(102 pages)
29 Aug 2019	AP01	Appointment of Daniel Mark Bradbury as a director on 29 July 2019	(2 pages)
29 Aug 2019	TM01	Termination of appointment of Kiran Mazumdar Shaw as a director on 29 July 2019	(1 page)
14 May 2019	SH01	Statement of capital following an allotment of shares on 29 March 2019 GBP 116,771,297	(3 pages)
24 Apr 2019	CS01	Confirmation statement made on 2 March 2019 with updates	(5 pages)
17 Jul 2018	SH01	Statement of capital following an allotment of shares on 30 June 2018 GBP 116,001,746	(4 pages)
11 Jul 2018	AA	Group of companies' accounts made up to 31 March 2018	(47 pages)
08 May 2018	CS01	Confirmation statement made on 2 March 2018 with updates	(5 pages)
18 Feb 2018	SH01	Statement of capital following an allotment of shares on 1 January 2018 GBP 97,722,710	(3 pages)
09 Nov 2017	AA	Full accounts made up to 31 March 2017	(43 pages)
26 Oct 2017	SH01	Statement of capital following an allotment of shares on 28 August 2017 GBP 80,260,024	(3 pages)
26 Oct 2017	SH01	Statement of capital following an allotment of shares on 14 June 2017 GBP 70,260,024	(3 pages)
01 Oct 2017	AP01	Appointment of John Mccallum Marshall Shaw as a director on 28 August 2017	(2 pages)